Bharat Biotech has so far invested over ₹500 crores at risk from its own resources for product development, clinical trials and setting up of manufacturing facilities for Covaxin.
National

₹150 per Covaxin dose to Centre not sustainable in long run: Bharat Biotech

Special Correspondent
The Novavax vaccine, which is easy to store and transport, is expected to play an important role in boosting vaccine supplies in the developing world.
Health

Coronavirus | Novavax claims 90% efficacy for its vaccine

Sriram Lakshman

Other Articles